BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 7004190)

  • 1. Three metronidazole-resistant strains of Trichomonas vaginalis from the United States.
    Müller M; Meingassner JG; Miller WA; Ledger WJ
    Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 1):808-12. PubMed ID: 7004190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metronidazole resistance of Trichomonas vaginalis as a cause of treatment failure in trichomoniasis--A case report.
    Kulda J; Vojtĕchovská M; Tachezy J; Demes P; Kunzová E
    Br J Vener Dis; 1982 Dec; 58(6):394-9. PubMed ID: 6983379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis.
    Lossick JG; Müller M; Gorrell TE
    J Infect Dis; 1986 May; 153(5):948-55. PubMed ID: 3486237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis.
    Müller M; Lossick JG; Gorrell TE
    Sex Transm Dis; 1988; 15(1):17-24. PubMed ID: 3258675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
    Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S
    Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
    Seña AC; Bachmann LH; Hobbs MM
    Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of Trichomonas vaginalis strains to metronidazole: response to treatment.
    Ralph ED; Darwish R; Austin TW; Smith EA; Pattison FL
    Sex Transm Dis; 1983; 10(3):119-22. PubMed ID: 6359490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of metronidazole-resistant Trichomonas vaginalis with tinidazole: case reports of three patients.
    Hager WD
    Sex Transm Dis; 2004 Jun; 31(6):343-5. PubMed ID: 15167642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic.
    Schmid G; Narcisi E; Mosure D; Secor WE; Higgins J; Moreno H
    J Reprod Med; 2001 Jun; 46(6):545-9. PubMed ID: 11441678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis.
    Crowell AL; Sanders-Lewis KA; Secor WE
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1407-9. PubMed ID: 12654679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metronidazole-resistant Trichomonas vaginalis.
    Forsgren A; Forssman L
    Br J Vener Dis; 1979 Oct; 55(5):351-3. PubMed ID: 315809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of antimicrobial susceptibility testing in Trichomonas vaginalis-infected women with clinical treatment failure.
    Bosserman EA; Helms DJ; Mosure DJ; Secor WE; Workowski KA
    Sex Transm Dis; 2011 Oct; 38(10):983-7. PubMed ID: 21934577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Povidone-iodine in the treatment of metronidazole-resistant trichomonas vaginalis.
    Wong CA; Wilson PD; Chew TA
    Aust N Z J Obstet Gynaecol; 1990 May; 30(2):169-71. PubMed ID: 2400364
    [No Abstract]   [Full Text] [Related]  

  • 14. The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population.
    Abdel-Magied AA; El-Kholya EI; Abou El-Khair SM; Abdelmegeed ES; Hamoudaa MM; Mohamed SA; El-Tantawy NL
    Parasitol Res; 2017 Nov; 116(11):3125-3130. PubMed ID: 28956167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations.
    Meri T; Jokiranta TS; Suhonen L; Meri S
    J Clin Microbiol; 2000 Feb; 38(2):763-7. PubMed ID: 10655382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of nitazoxanide against some metronidazole-resistant and susceptible Trichomonas vaginalis isolates.
    Abdel-Magied AA; Hammouda MM; Mosbah A; El-Henawy AA
    J Infect Chemother; 2017 Apr; 23(4):230-233. PubMed ID: 28131737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.
    Cudmore SL; Delgaty KL; Hayward-McClelland SF; Petrin DP; Garber GE
    Clin Microbiol Rev; 2004 Oct; 17(4):783-93, table of contents. PubMed ID: 15489348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic aspects of trichomoniasis].
    Vukićević J; Jankicević J
    Srp Arh Celok Lek; 2003; 131(3-4):156-61. PubMed ID: 14608880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring the in vitro susceptibility of Trichomonas vaginalis to metronidazole: a disk broth method.
    Smith RF; Di Domenico A
    Sex Transm Dis; 1980; 7(3):120-4. PubMed ID: 6969450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of Trichomonas vaginalis resistant to metronidazole.
    Thurner J; Meingassner JG
    Lancet; 1978 Sep; 2(8092 Pt 1):738. PubMed ID: 80664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.